Showing 1 - 4 results of 4 for search 'Kari Lenita Falck Moore', query time: 0.02s Refine Results
  1. 1
    Incidence and prevention of skeletal‐related events in multiple myeloma patients: A population‐based real‐world experience

    Incidence and prevention of skeletal‐related events in multiple myeloma patients: A population‐based real‐world experience by Marie Røra, Margrete Skretting Solberg, Kari Lenita Falck Moore, Tobias S. Slørdahl

    Published 2024-08-01
    Get full text
    Article
  2. 2
    P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY

    P969: VRD OUTPERFORMED VCD AS INDUCTION THERAPY BEFORE FIRST-LINE ASCT IN MULITPLE MYELOMA; RESULTS FROM A NATIONWIDE, POPULATION-BASED STUDY by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold

    Published 2023-08-01
    Get full text
    Article
  3. 3
    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study

    VRD versus VCD as induction therapy before autologous stem cell transplantation in multiple myeloma: a nationwide population-based study by Jakob Nordberg Nørgaard, Kari Lenita Falck Moore, Tobias S. Slørdahl, Anders Vik, Tor Henrik Anderson Tvedt, Fredrik Schjesvold

    Published 2024-04-01
    Get full text
    Article
  4. 4
    Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden

    Improved survival in myeloma patients–a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden by Kari Lenita Falck Moore, Ingemar Turesson, Anna Genell, Tobias W. Klausen, Dorota Knut-Bojanowska, Louise Redder, Ingigerdur Sverrisdottir, Jonathan Thorsen, Annette J. Vangsted, Cecilie H. Blimark

    Published 2022-10-01
    Get full text
    Article

Search Tools: